▶ 調査レポート

世界のボルチオキセチン市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Vortioxetine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

が調査・発行した産業分析レポートです。世界のボルチオキセチン市場 2021:企業別、地域別、種類・用途別 / Global Vortioxetine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-105X15274資料のイメージです。• レポートコード:GIR-105X15274
• 出版社/出版日: / 2021年5月
• レポート形態:英文、PDF、108ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:Pharma & Healthcare
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、ボルチオキセチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ボルチオキセチンの種類別市場規模(5mg錠、10Mg錠、15Mg錠、20Mg錠)、用途別市場規模(うつ病、全般性不安障害、注意欠陥多動性障害、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・ボルチオキセチンの市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Takeda、Lundbeck、CGeneTech
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:5mg錠、10Mg錠、15Mg錠、20Mg錠
・用途別分析2016年-2026年:うつ病、全般性不安障害、注意欠陥多動性障害、その他
・ボルチオキセチンの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・ボルチオキセチンのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・ボルチオキセチンのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・ボルチオキセチンの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・ボルチオキセチンの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Vortioxetine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Vortioxetine size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Vortioxetine market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Vortioxetine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
5 Mg Tablets
10 Mg Tablet
15 Mg Tablet
20 Mg Tablet

Market segment by Application can be divided into
Depression
Generalized Anxiety Disorder
Attention Deficit Hyperactivity Disorder
Other

The key market players for global Vortioxetine market are listed below:
Takeda
Lundbeck
CGeneTech

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Vortioxetine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vortioxetine, with price, sales, revenue and global market share of Vortioxetine in 2018 and 2019.
Chapter 3, the Vortioxetine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vortioxetine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Vortioxetine market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Vortioxetine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Vortioxetine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Vortioxetine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 5 Mg Tablets
1.2.3 10 Mg Tablet
1.2.4 15 Mg Tablet
1.2.5 20 Mg Tablet
1.3 Market Analysis by Application
1.3.1 Overview: Global Vortioxetine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Depression
1.3.3 Generalized Anxiety Disorder
1.3.4 Attention Deficit Hyperactivity Disorder
1.3.5 Other
1.4 Global Vortioxetine Market Size & Forecast
1.4.1 Global Vortioxetine Sales in Value (2016-2026))
1.4.2 Global Vortioxetine Sales in Volume (2016-2026)
1.4.3 Global Vortioxetine Price by Type (2016-2026) & (US$/Pcs)
1.5 Global Vortioxetine Production Capacity Analysis
1.5.1 Global Vortioxetine Total Production Capacity (2016-2026)
1.5.2 Global Vortioxetine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Vortioxetine Market Drivers
1.6.2 Vortioxetine Market Restraints
1.6.3 Vortioxetine Trends Analysis
2 Manufacturers Profiles
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Vortioxetine Product and Services
2.1.4 Takeda Vortioxetine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Lundbeck
2.2.1 Lundbeck Details
2.2.2 Lundbeck Major Business
2.2.3 Lundbeck Vortioxetine Product and Services
2.2.4 Lundbeck Vortioxetine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 CGeneTech
2.3.1 CGeneTech Details
2.3.2 CGeneTech Major Business
2.3.3 CGeneTech Vortioxetine Product and Services
2.3.4 CGeneTech Vortioxetine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Vortioxetine Sales by Manufacturer
3.1 Global Vortioxetine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Vortioxetine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Vortioxetine
3.4 Market Concentration Rate
3.4.1 Top 3 Vortioxetine Manufacturer Market Share
3.4.2 Top 6 Vortioxetine Manufacturer Market Share
3.5 Global Vortioxetine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Vortioxetine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Vortioxetine Market Size by Region
4.1.1 Global Vortioxetine Sales in Volume by Region (2016-2026)
4.1.2 Global Vortioxetine Revenue by Region (2016-2026)
4.2 North America Vortioxetine Revenue (2016-2026)
4.3 Europe Vortioxetine Revenue (2016-2026)
4.4 Asia-Pacific Vortioxetine Revenue (2016-2026)
4.5 South America Vortioxetine Revenue (2016-2026)
4.6 Middle East and Africa Vortioxetine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Vortioxetine Sales in Volume by Type (2016-2026)
5.2 Global Vortioxetine Revenue by Type (2016-2026)
5.3 Global Vortioxetine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Vortioxetine Sales in Volume by Application (2016-2026)
6.2 Global Vortioxetine Revenue by Application (2016-2026)
6.3 Global Vortioxetine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Vortioxetine Sales by Type (2016-2026)
7.2 North America Vortioxetine Sales by Application (2016-2026)
7.3 North America Vortioxetine Market Size by Country
7.3.1 North America Vortioxetine Sales in Volume by Country (2016-2026)
7.3.2 North America Vortioxetine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Vortioxetine Sales by Type (2016-2026)
8.2 Europe Vortioxetine Sales by Application (2016-2026)
8.3 Europe Vortioxetine Market Size by Country
8.3.1 Europe Vortioxetine Sales in Volume by Country (2016-2026)
8.3.2 Europe Vortioxetine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Vortioxetine Sales by Type (2016-2026)
9.2 Asia-Pacific Vortioxetine Sales by Application (2016-2026)
9.3 Asia-Pacific Vortioxetine Market Size by Region
9.3.1 Asia-Pacific Vortioxetine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Vortioxetine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Vortioxetine Sales by Type (2016-2026)
10.2 South America Vortioxetine Sales by Application (2016-2026)
10.3 South America Vortioxetine Market Size by Country
10.3.1 South America Vortioxetine Sales in Volume by Country (2016-2026)
10.3.2 South America Vortioxetine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Vortioxetine Sales by Type (2016-2026)
11.2 Middle East & Africa Vortioxetine Sales by Application (2016-2026)
11.3 Middle East & Africa Vortioxetine Market Size by Country
11.3.1 Middle East & Africa Vortioxetine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Vortioxetine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Vortioxetine Typical Distributors
12.3 Vortioxetine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Vortioxetine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Vortioxetine Revenue by Application, (USD Million), 2021-2026
Table 3. Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Major Business
Table 5. Takeda Vortioxetine Product and Services
Table 6. Takeda Vortioxetine Sales (M Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 8. Lundbeck Major Business
Table 9. Lundbeck Vortioxetine Product and Services
Table 10. Lundbeck Vortioxetine Sales (M Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. CGeneTech Basic Information, Manufacturing Base and Competitors
Table 12. CGeneTech Major Business
Table 13. CGeneTech Vortioxetine Product and Services
Table 14. CGeneTech Vortioxetine Sales (M Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Global Vortioxetine Sales by Manufacturer (2019-2021e) & (M Pcs)
Table 16. Global Vortioxetine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 17. Market Position of Manufacturers in Vortioxetine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 18. Global Vortioxetine Production Capacity by Company, (M Pcs): 2020 VS 2021
Table 19. Head Office and Vortioxetine Production Site of Key Manufacturer
Table 20. Vortioxetine New Entrant and Capacity Expansion Plans
Table 21. Vortioxetine Mergers & Acquisitions in the Past Five Years
Table 22. Global Vortioxetine Sales by Region (2016-2021e) & (M Pcs)
Table 23. Global Vortioxetine Sales by Region (2021-2026) & (M Pcs)
Table 24. Global Vortioxetine Revenue by Region (2016-2021e) & (USD Million)
Table 25. Global Vortioxetine Revenue by Region (2021-2026) & (USD Million)
Table 26. Global Vortioxetine Sales by Type (2016-2021e) & (M Pcs)
Table 27. Global Vortioxetine Sales by Type (2021-2026) & (M Pcs)
Table 28. Global Vortioxetine Revenue by Type (2016-2021e) & (USD Million)
Table 29. Global Vortioxetine Revenue by Type (2021-2026) & (USD Million)
Table 30. Global Vortioxetine Price by Type (2016-2021e) & (US$/Pcs)
Table 31. Global Vortioxetine Price by Type (2021-2026) & (US$/Pcs)
Table 32. Global Vortioxetine Sales by Application (2016-2021e) & (M Pcs)
Table 33. Global Vortioxetine Sales by Application (2021-2026) & (M Pcs)
Table 34. Global Vortioxetine Revenue by Application (2016-2021e) & (USD Million)
Table 35. Global Vortioxetine Revenue by Application (2021-2026) & (USD Million)
Table 36. Global Vortioxetine Price by Application (2016-2021e) & (US$/Pcs)
Table 37. Global Vortioxetine Price by Application (2021-2026) & (US$/Pcs)
Table 38. North America Vortioxetine Sales by Country (2016-2021e) & (M Pcs)
Table 39. North America Vortioxetine Sales by Country (2021-2026) & (M Pcs)
Table 40. North America Vortioxetine Revenue by Country (2016-2021e) & (USD Million)
Table 41. North America Vortioxetine Revenue by Country (2021-2026) & (USD Million)
Table 42. North America Vortioxetine Sales by Type (2016-2021e) & (M Pcs)
Table 43. North America Vortioxetine Sales by Type (2021-2026) & (M Pcs)
Table 44. North America Vortioxetine Sales by Application (2016-2021e) & (M Pcs)
Table 45. North America Vortioxetine Sales by Application (2021-2026) & (M Pcs)
Table 46. Europe Vortioxetine Sales by Country (2016-2021e) & (M Pcs)
Table 47. Europe Vortioxetine Sales by Country (2021-2026) & (M Pcs)
Table 48. Europe Vortioxetine Revenue by Country (2016-2021e) & (USD Million)
Table 49. Europe Vortioxetine Revenue by Country (2021-2026) & (USD Million)
Table 50. Europe Vortioxetine Sales by Type (2016-2021e) & (M Pcs)
Table 51. Europe Vortioxetine Sales by Type (2021-2026) & (M Pcs)
Table 52. Europe Vortioxetine Sales by Application (2016-2021e) & (M Pcs)
Table 53. Europe Vortioxetine Sales by Application (2021-2026) & (M Pcs)
Table 54. Asia-Pacific Vortioxetine Sales by Region (2016-2021e) & (M Pcs)
Table 55. Asia-Pacific Vortioxetine Sales by Region (2021-2026) & (M Pcs)
Table 56. Asia-Pacific Vortioxetine Revenue by Region (2016-2021e) & (USD Million)
Table 57. Asia-Pacific Vortioxetine Revenue by Region (2021-2026) & (USD Million)
Table 58. Asia-Pacific Vortioxetine Sales by Type (2016-2021e) & (M Pcs)
Table 59. Asia-Pacific Vortioxetine Sales by Type (2021-2026) & (M Pcs)
Table 60. Asia-Pacific Vortioxetine Sales by Application (2016-2021e) & (M Pcs)
Table 61. Asia-Pacific Vortioxetine Sales by Application (2021-2026) & (M Pcs)
Table 62. South America Vortioxetine Sales by Country (2016-2021e) & (M Pcs)
Table 63. South America Vortioxetine Sales by Country (2021-2026) & (M Pcs)
Table 64. South America Vortioxetine Revenue by Country (2016-2021e) & (USD Million)
Table 65. South America Vortioxetine Revenue by Country (2021-2026) & (USD Million)
Table 66. South America Vortioxetine Sales by Type (2016-2021e) & (M Pcs)
Table 67. South America Vortioxetine Sales by Type (2021-2026) & (M Pcs)
Table 68. South America Vortioxetine Sales by Application (2016-2021e) & (M Pcs)
Table 69. South America Vortioxetine Sales by Application (2021-2026) & (M Pcs)
Table 70. Middle East & Africa Vortioxetine Sales by Country (2016-2021e) & (M Pcs)
Table 71. Middle East & Africa Vortioxetine Sales by Country (2021-2026) & (M Pcs)
Table 72. Middle East & Africa Vortioxetine Revenue by Country (2016-2021e) & (USD Million)
Table 73. Middle East & Africa Vortioxetine Revenue by Country (2021-2026) & (USD Million)
Table 74. Middle East & Africa Vortioxetine Sales by Type (2016-2021e) & (M Pcs)
Table 75. Middle East & Africa Vortioxetine Sales by Type (2021-2026) & (M Pcs)
Table 76. Middle East & Africa Vortioxetine Sales by Application (2016-2021e) & (M Pcs)
Table 77. Middle East & Africa Vortioxetine Sales by Application (2021-2026) & (M Pcs)
Table 78. Direct Channel Pros & Cons
Table 79. Indirect Channel Pros & Cons
Table 80. Vortioxetine Typical Distributors
Table 81. Vortioxetine Typical Customers
List of Figures
Figure 1. Vortioxetine Picture
Figure 2. Global Vortioxetine Sales Market Share by Type in 2020
Figure 3. 5 Mg Tablets
Figure 4. 10 Mg Tablet
Figure 5. 15 Mg Tablet
Figure 6. 20 Mg Tablet
Figure 7. Global Vortioxetine Sales Market Share by Application in 2020
Figure 8. Depression
Figure 9. Generalized Anxiety Disorder
Figure 10. Attention Deficit Hyperactivity Disorder
Figure 11. Other
Figure 12. Global Vortioxetine Market Size, (USD Million) & (M Pcs): 2020 VS 2021 VS 2026
Figure 13. Global Vortioxetine Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Vortioxetine Sales (2016-2026) & (M Pcs)
Figure 15. Global Vortioxetine Price by Type (2016-2026) & (US$/Pcs)
Figure 16. Global Vortioxetine Production Capacity (2016-2026) & (M Pcs)
Figure 17. Global Vortioxetine Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Vortioxetine Market Drivers
Figure 19. Vortioxetine Market Restraints
Figure 20. Vortioxetine Market Trends
Figure 21. Global Vortioxetine Sales Market Share by Manufacturer in 2020
Figure 22. Global Vortioxetine Revenue Market Share by Manufacturer in 2020
Figure 23. Vortioxetine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Vortioxetine Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Vortioxetine Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Vortioxetine Sales Market Share by Region (2016-2026)
Figure 27. Global Vortioxetine Revenue Market Share by Region (2016-2026)
Figure 28. North America Vortioxetine Revenue (2016-2026) & (USD Million)
Figure 29. Europe Vortioxetine Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Vortioxetine Revenue (2016-2026) & (USD Million)
Figure 31. South America Vortioxetine Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Vortioxetine Revenue (2016-2026) & (USD Million)
Figure 33. Global Vortioxetine Sales Market Share by Type (2016-2026)
Figure 34. Global Vortioxetine Revenue Market Share by Type (2016-2026)
Figure 35. Global Vortioxetine Price by Type (2016-2026) & (US$/Pcs)
Figure 36. Global Vortioxetine Sales Market Share by Application (2016-2026)
Figure 37. Global Vortioxetine Revenue Market Share by Application (2016-2026)
Figure 38. Global Vortioxetine Price by Application (2016-2026) & (US$/Pcs)
Figure 39. North America Vortioxetine Sales Market Share by Type (2016-2026)
Figure 40. North America Vortioxetine Sales Market Share by Application (2016-2026)
Figure 41. North America Vortioxetine Sales Market Share by Country (2016-2026)
Figure 42. North America Vortioxetine Revenue Market Share by Country (2016-2026)
Figure 43. United States Vortioxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Vortioxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Vortioxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Vortioxetine Sales Market Share by Type (2016-2026)
Figure 47. Europe Vortioxetine Sales Market Share by Application (2016-2026)
Figure 48. Europe Vortioxetine Sales Market Share by Country (2016-2026)
Figure 49. Europe Vortioxetine Revenue Market Share by Country (2016-2026)
Figure 50. Germany Vortioxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Vortioxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Vortioxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Vortioxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Vortioxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Vortioxetine Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Vortioxetine Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Vortioxetine Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Vortioxetine Revenue Market Share by Region (2016-2026)
Figure 59. China Vortioxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Vortioxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Vortioxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Vortioxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Vortioxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Vortioxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Vortioxetine Sales Market Share by Type (2016-2026)
Figure 66. South America Vortioxetine Sales Market Share by Application (2016-2026)
Figure 67. South America Vortioxetine Sales Market Share by Country (2016-2026)
Figure 68. South America Vortioxetine Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Vortioxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Vortioxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Vortioxetine Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Vortioxetine Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Vortioxetine Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Vortioxetine Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Vortioxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Vortioxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Vortioxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Vortioxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source